| Year |
Citation |
Score |
| 2023 |
Singh DR, Nelson SE, Pawelski AS, Kansra AS, Fogarty SA, Bristol JA, Ohashi M, Johannsen EC, Kenney SC. Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ. Proceedings of the National Academy of Sciences of the United States of America. 120: e2219755120. PMID 37155846 DOI: 10.1073/pnas.2219755120 |
0.425 |
|
| 2022 |
Ali A, Ohashi M, Casco A, Djavadian R, Eichelberg M, Kenney SC, Johannsen E. Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription. Plos Pathogens. 18: e1010886. PMID 36174106 DOI: 10.1371/journal.ppat.1010886 |
0.502 |
|
| 2022 |
Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: Biology and clinical disease. Cell. 185: 3652-3670. PMID 36113467 DOI: 10.1016/j.cell.2022.08.026 |
0.332 |
|
| 2021 |
Van Sciver N, Ohashi M, Nawandar DM, Pauly NP, Lee D, Makielski KR, Bristol JA, Tsao SW, Lambert PF, Johannsen EC, Kenney SC. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. Plos Pathogens. 17: e1010045. PMID 34748616 DOI: 10.1371/journal.ppat.1010045 |
0.498 |
|
| 2021 |
Van Sciver N, Ohashi M, Pauly NP, Bristol JA, Nelson SE, Johannsen EC, Kenney SC. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. Plos Pathogens. 17: e1009783. PMID 34339458 DOI: 10.1371/journal.ppat.1009783 |
0.447 |
|
| 2020 |
Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, Scott RS, Johannsen EC, Kenney SC. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. Plos Pathogens. 16: e1008590. PMID 32542010 DOI: 10.1371/Journal.Ppat.1008590 |
0.356 |
|
| 2020 |
Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Zumwalde NA, Bristol JA, Nelson SE, Ma S, Ranheim EA, Gumperz JE, Johannsen EC, Kenney SC. An EBNA3A-mutated Epstein-Barr virus (EBV) retains the capacity for lymphomagenesis in a cord blood-humanized mouse model. Journal of Virology. PMID 32132242 DOI: 10.1128/JVI.02168-19 |
0.357 |
|
| 2020 |
Romero-Masters JC, Huebner SM, Ohashi M, Bristol JA, Benner BE, Barlow EA, Turk GL, Nelson SE, Baiu DC, Van Sciver N, Ranheim EA, Gumperz J, Sherer NM, Farrell PJ, Johannsen EC, ... Kenney SC, et al. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. Plos Pathogens. 16: e1008365. PMID 32059024 DOI: 10.1371/Journal.Ppat.1008365 |
0.302 |
|
| 2019 |
Eichelberg MR, Welch R, Guidry JT, Ali A, Ohashi M, Makielski KR, McChesney K, Van Sciver N, Lambert PF, Keleș S, Kenney SC, Scott RS, Johannsen E. Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle. Mbio. 10. PMID 31431547 DOI: 10.1128/Mbio.01332-19 |
0.369 |
|
| 2018 |
Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, Kenney SC. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. Plos Pathogens. 14: e1007221. PMID 30125329 DOI: 10.1371/journal.ppat.1007221 |
0.352 |
|
| 2018 |
Bristol JA, Djavadian R, Albright ER, Coleman CB, Ohashi M, Hayes M, Romero-Masters JC, Barlow EA, Farrell PJ, Rochford R, Kalejta RF, Johannsen EC, Kenney SC. A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. Plos Pathogens. 14: e1007179. PMID 30052684 DOI: 10.1371/Journal.Ppat.1007179 |
0.382 |
|
| 2018 |
Hoebe E, Wille C, Hagemeier S, Kenney S, Greijer A, Middeldorp J. Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma. Cancers. 10. PMID 29562599 DOI: 10.3390/cancers10030076 |
0.527 |
|
| 2017 |
Tikhmyanova N, Tutton S, Martin KA, Lu F, Kossenkov AV, Paparoidamis N, Kenney S, Salvino JM, Lieberman PM. Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation. Plos Pathogens. 13: e1006517. PMID 28715492 DOI: 10.1371/Journal.Ppat.1006517 |
0.42 |
|
| 2017 |
Kraus RJ, Yu X, Cordes BA, Sathiamoorthi S, Iempridee T, Nawandar DM, Ma S, Romero-Masters JC, McChesney KG, Lin Z, Makielski KR, Lee DL, Lambert PF, Johannsen EC, Kenney SC, et al. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. Plos Pathogens. 13: e1006404. PMID 28617871 DOI: 10.1371/Journal.Ppat.1006404 |
0.347 |
|
| 2017 |
Bilger A, Plowshay J, Ma S, Nawandar D, Barlow EA, Romero-Masters JC, Bristol JA, Li Z, Tsai MH, Delecluse HJ, Kenney SC. Leflunomide/teriflunomide inhibit Epstein-barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication. Oncotarget. PMID 28574826 DOI: 10.18632/Oncotarget.17863 |
0.345 |
|
| 2017 |
Nawandar DM, Ohashi M, Djavadian R, Barlow E, Makielski K, Ali A, Lee D, Lambert PF, Johannsen E, Kenney SC. Differentiation-dependent LMP1 expression is required for efficient lytic EBV reactivation in epithelial cells. Journal of Virology. PMID 28179525 DOI: 10.1128/Jvi.02438-16 |
0.45 |
|
| 2016 |
Wille CK, Li Y, Rui L, Johannsen EC, Kenney SC. Restricted TET2 expression in germinal center type B cells promotes stringent Epstein-Barr virus latency. Journal of Virology. PMID 28003489 DOI: 10.1128/JVI.01987-16 |
0.334 |
|
| 2016 |
Golden S, Yu XM, Odorico S, Jain V, Marin A, Ma S, Kenney S, Chen H. The Epstein-Barr virus EBNA2 protein induces a subset of NOTCH target genes in thyroid cancer cell lines but fails to suppress proliferation. Surgery. PMID 27847111 DOI: 10.1016/j.surg.2016.06.068 |
0.484 |
|
| 2015 |
Wille CK, Nawandar DM, Henning AN, Ma S, Oetting KM, Lee D, Lambert P, Johannsen EC, Kenney SC. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch. Proceedings of the National Academy of Sciences of the United States of America. PMID 26663912 DOI: 10.1073/Pnas.1513432112 |
0.444 |
|
| 2015 |
Kenney SP, Wentworth JL, Heffron CL, Meng XJ. Replacement of the hepatitis E virus ORF3 protein PxxP motif with heterologous late domain motifs affects virus release via interaction with TSG101. Virology. 486: 198-208. PMID 26457367 DOI: 10.1016/J.Virol.2015.09.012 |
0.317 |
|
| 2015 |
Nawandar DM, Wang A, Makielski K, Lee D, Ma S, Barlow E, Reusch J, Jiang R, Wille CK, Greenspan D, Greenspan JS, Mertz JE, Hutt-Fletcher L, Johannsen EC, Lambert PF, ... Kenney SC, et al. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells. Plos Pathogens. 11: e1005195. PMID 26431332 DOI: 10.1371/Journal.Ppat.1005195 |
0.395 |
|
| 2015 |
Kenney SP, Meng XJ. An SH3 binding motif within the nucleocapsid protein of porcine reproductive and respiratory syndrome virus interacts with the host cellular signaling proteins STAMI, TXK, Fyn, Hck, and cortactin. Virus Research. 204: 31-9. PMID 25882913 DOI: 10.1016/J.Virusres.2015.04.004 |
0.359 |
|
| 2015 |
Kenney SP, Meng XJ. The lysine residues within the human ribosomal protein S17 sequence naturally inserted into the viral nonstructural protein of a unique strain of hepatitis E virus are important for enhanced virus replication. Journal of Virology. 89: 3793-803. PMID 25609799 DOI: 10.1128/Jvi.03582-14 |
0.348 |
|
| 2015 |
Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters. Journal of Virology. 89: 1731-43. PMID 25410866 DOI: 10.1128/Jvi.02781-14 |
0.463 |
|
| 2014 |
Iempridee T, Reusch JA, Riching A, Johannsen EC, Dovat S, Kenney SC, Mertz JE. Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. Journal of Virology. 88: 4811-27. PMID 24522918 DOI: 10.1128/Jvi.03706-13 |
0.51 |
|
| 2014 |
Kenney SC, Mertz JE. Regulation of the latent-lytic switch in Epstein-Barr virus. Seminars in Cancer Biology. 26: 60-8. PMID 24457012 DOI: 10.1016/J.Semcancer.2014.01.002 |
0.353 |
|
| 2013 |
Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. Journal of Virology. 87: 10126-38. PMID 23843639 DOI: 10.1128/Jvi.01671-13 |
0.406 |
|
| 2013 |
Raver RM, Panfil AR, Hagemeier SR, Kenney SC. The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1. Journal of Virology. 87: 8053-63. PMID 23678172 DOI: 10.1128/JVI.00546-13 |
0.529 |
|
| 2013 |
Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. Journal of Virology. 87: 935-50. PMID 23135711 DOI: 10.1128/Jvi.01790-12 |
0.45 |
|
| 2012 |
Hagemeier SR, Barlow EA, Meng Q, Kenney SC. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. Journal of Virology. 86: 13360-70. PMID 23015717 DOI: 10.1128/JVI.01850-12 |
0.434 |
|
| 2012 |
Hoebe EK, Wille C, Hopmans ES, Robinson AR, Middeldorp JM, Kenney SC, Greijer AE. Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation. Journal of Virology. 86: 11322-32. PMID 22896599 DOI: 10.1128/JVI.01161-12 |
0.474 |
|
| 2012 |
Ma SD, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, Tang W, Burlingham WJ, Gulley ML, Kenney SC. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. Journal of Virology. 86: 7976-87. PMID 22623780 DOI: 10.1128/Jvi.00770-12 |
0.404 |
|
| 2012 |
Kenney SP, Pudupakam RS, Huang YW, Pierson FW, LeRoith T, Meng XJ. The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release. Journal of Virology. 86: 5637-46. PMID 22438540 DOI: 10.1128/JVI.06711-11 |
0.366 |
|
| 2012 |
Robinson AR, Kwek SS, Kenney SC. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1. Plos Pathogens. 8: e1002516. PMID 22346751 DOI: 10.1371/journal.ppat.1002516 |
0.503 |
|
| 2011 |
Pudupakam RS, Kenney SP, Córdoba L, Huang YW, Dryman BA, Leroith T, Pierson FW, Meng XJ. Mutational analysis of the hypervariable region of hepatitis e virus reveals its involvement in the efficiency of viral RNA replication. Journal of Virology. 85: 10031-40. PMID 21775444 DOI: 10.1128/JVI.00763-11 |
0.329 |
|
| 2011 |
Robinson AR, Kwek SS, Hagemeier SR, Wille CK, Kenney SC. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency. Journal of Virology. 85: 8940-53. PMID 21697476 DOI: 10.1128/JVI.00569-11 |
0.535 |
|
| 2011 |
Hagemeier SR, Barlow EA, Kleman AA, Kenney SC. The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner. Journal of Virology. 85: 4318-29. PMID 21325409 DOI: 10.1128/JVI.01856-10 |
0.439 |
|
| 2011 |
Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, Jankowska-Gan E, Burlingham WJ, Sun X, Gulley ML, Tang W, Gumperz JE, Kenney SC. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. Journal of Virology. 85: 165-77. PMID 20980506 DOI: 10.1128/Jvi.01512-10 |
0.367 |
|
| 2010 |
Bristol JA, Robinson AR, Barlow EA, Kenney SC. The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins. Journal of Virology. 84: 12362-74. PMID 20861254 DOI: 10.1128/JVI.00712-10 |
0.379 |
|
| 2010 |
Hagemeier SR, Dickerson SJ, Meng Q, Yu X, Mertz JE, Kenney SC. Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase. Journal of Virology. 84: 4383-94. PMID 20181712 DOI: 10.1128/Jvi.02369-09 |
0.52 |
|
| 2010 |
Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. Journal of Virology. 84: 4534-42. PMID 20181711 DOI: 10.1128/JVI.02487-09 |
0.377 |
|
| 2010 |
Meng Q, Hagemeier SR, Kuny CV, Kalejta RF, Kenney SC. Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant. Journal of Virology. 84: 4524-33. PMID 20147387 DOI: 10.1128/Jvi.02456-09 |
0.33 |
|
| 2010 |
Sun X, Barlow EA, Ma S, Hagemeier SR, Duellman SJ, Burgess RR, Tellam J, Khanna R, Kenney SC. Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proceedings of the National Academy of Sciences of the United States of America. 107: 3146-51. PMID 20133771 DOI: 10.1073/Pnas.0910717107 |
0.355 |
|
| 2009 |
Ryan JL, Jones RJ, Elmore SH, Kenney SC, Miller G, Schroeder JC, Gulley ML. Epstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo. Intervirology. 52: 8-16. PMID 19349713 DOI: 10.1159/000210833 |
0.351 |
|
| 2009 |
Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC. Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters. Plos Pathogens. 5: e1000356. PMID 19325883 DOI: 10.1371/Journal.Ppat.1000356 |
0.455 |
|
| 2008 |
Kenney SP, Lochmann TL, Schmid CL, Parent LJ. Intermolecular interactions between retroviral Gag proteins in the nucleus. Journal of Virology. 82: 683-91. PMID 17977961 DOI: 10.1128/Jvi.02049-07 |
0.301 |
|
| 2007 |
Feng WH, Kraus RJ, Dickerson SJ, Lim HJ, Jones RJ, Yu X, Mertz JE, Kenney SC. ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells. Journal of Virology. 81: 10113-22. PMID 17626078 DOI: 10.1128/Jvi.00692-07 |
0.355 |
|
| 2007 |
Yu F, Feng J, Harada JN, Chanda SK, Kenney SC, Sun R. B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. Febs Letters. 581: 3485-8. PMID 17617410 DOI: 10.1016/J.Febslet.2007.06.056 |
0.386 |
|
| 2007 |
Bhende PM, Dickerson SJ, Sun X, Feng WH, Kenney SC. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. Journal of Virology. 81: 7363-70. PMID 17494074 DOI: 10.1128/Jvi.00154-07 |
0.519 |
|
| 2007 |
Jones RJ, Dickerson S, Bhende PM, Delecluse HJ, Kenney SC. Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme, DHRS9. The Journal of Biological Chemistry. 282: 8317-24. PMID 17244623 DOI: 10.1074/jbc.M608667200 |
0.41 |
|
| 2007 |
Knight ERW, Tang W, Ryan JL, Kenney S, Gulley ML. Epstein‐Barr Infection Does Not Affect Cyclooxygenase‐2 Protein Expression in Gastric Cancer The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A382-A |
0.308 |
|
| 2006 |
Feng WH, Kenney SC. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression. Cancer Research. 66: 8762-9. PMID 16951192 DOI: 10.1158/0008-5472.CAN-06-1006 |
0.362 |
|
| 2006 |
González CM, Wong EL, Bowser BS, Hong GK, Kenney S, Damania B. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus. Journal of Virology. 80: 3062-70. PMID 16501115 DOI: 10.1128/Jvi.80.6.3062-3070.2006 |
0.547 |
|
| 2005 |
Hong GK, Gulley ML, Feng WH, Delecluse HJ, Holley-Guthrie E, Kenney SC. Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. Journal of Virology. 79: 13993-4003. PMID 16254335 DOI: 10.1128/JVI.79.22.13993-14003.2005 |
0.404 |
|
| 2005 |
Hong GK, Kumar P, Wang L, Damania B, Gulley ML, Delecluse HJ, Polverini PJ, Kenney SC. Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. Journal of Virology. 79: 13984-92. PMID 16254334 DOI: 10.1128/Jvi.79.22.13984-13992.2005 |
0.322 |
|
| 2005 |
Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. Journal of Virology. 79: 7338-48. PMID 15919888 DOI: 10.1128/Jvi.79.12.7338-7348.2005 |
0.395 |
|
| 2005 |
Holley-Guthrie EA, Seaman WT, Bhende P, Merchant JL, Kenney SC. The Epstein-Barr virus protein BMRF1 activates gastrin transcription. Journal of Virology. 79: 745-55. PMID 15613302 DOI: 10.1128/Jvi.79.2.745-755.2005 |
0.458 |
|
| 2004 |
Li Y, Mahajan NP, Webster-Cyriaque J, Bhende P, Hong GK, Earp HS, Kenney S. The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1. Journal of Virology. 78: 11778-85. PMID 15479819 DOI: 10.1128/Jvi.78.21.11778-11785.2004 |
0.524 |
|
| 2004 |
Morrison TE, Kenney SC. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function. Virology. 328: 219-32. PMID 15464842 DOI: 10.1016/j.virol.2004.07.020 |
0.324 |
|
| 2004 |
Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nature Genetics. 36: 1099-104. PMID 15361873 DOI: 10.1038/Ng1424 |
0.431 |
|
| 2004 |
Makhov AM, Subramanian D, Holley-Guthrie E, Kenney SC, Griffith JD. The Epstein-Barr virus polymerase accessory factor BMRF1 adopts a ring-shaped structure as visualized by electron microscopy. The Journal of Biological Chemistry. 279: 40358-61. PMID 15286084 DOI: 10.1074/Jbc.M408733200 |
0.343 |
|
| 2004 |
Hong GK, Delecluse HJ, Gruffat H, Morrison TE, Feng WH, Sergeant A, Kenney SC. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1. Journal of Virology. 78: 4983-92. PMID 15113878 DOI: 10.1128/JVI.78.10.4983-4992.2004 |
0.486 |
|
| 2004 |
Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. Journal of Virology. 78: 4197-206. PMID 15047835 DOI: 10.1128/Jvi.78.8.4197-4206.2004 |
0.614 |
|
| 2004 |
Feng WH, Hong G, Delecluse HJ, Kenney SC. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. Journal of Virology. 78: 1893-902. PMID 14747554 DOI: 10.1128/JVI.78.4.1893-1902.2004 |
0.427 |
|
| 2003 |
Israel BF, Kenney SC. Virally targeted therapies for EBV-associated malignancies. Oncogene. 22: 5122-30. PMID 12910249 DOI: 10.1038/sj.onc.1206548 |
0.341 |
|
| 2002 |
Mauser A, Holley-Guthrie E, Zanation A, Yarborough W, Kaufmann W, Klingelhutz A, Seaman WT, Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. Journal of Virology. 76: 12543-52. PMID 12438580 DOI: 10.1128/Jvi.76.24.12543-12552.2002 |
0.481 |
|
| 2002 |
Mauser A, Saito S, Appella E, Anderson CW, Seaman WT, Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. Journal of Virology. 76: 12503-12. PMID 12438576 DOI: 10.1128/JVI.76.24.12503-12512.2002 |
0.493 |
|
| 2002 |
Feng WH, Westphal E, Mauser A, Raab-Traub N, Gulley ML, Busson P, Kenney SC. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. Journal of Virology. 76: 10951-9. PMID 12368338 DOI: 10.1128/Jvi.76.21.10951-10959.2002 |
0.302 |
|
| 2002 |
Mauser A, Holley-Guthrie E, Simpson D, Kaufmann W, Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block. Journal of Virology. 76: 10030-7. PMID 12208981 DOI: 10.1128/Jvi.76.19.10030-10037.2002 |
0.47 |
|
| 2001 |
Swenson JJ, Holley-Guthrie E, Kenney SC. Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation Journal of Virology. 75: 6228-6234. PMID 11390628 DOI: 10.1128/JVI.75.13.6228-6234.2001 |
0.482 |
|
| 2001 |
Darr CD, Mauser A, Kenney S. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation Journal of Virology. 75: 6135-6142. PMID 11390615 DOI: 10.1128/JVI.75.13.6135-6142.2001 |
0.537 |
|
| 2001 |
Adamson AL, Kenney S. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. Journal of Virology. 75: 2388-99. PMID 11160742 DOI: 10.1128/JVI.75.5.2388-2399.2001 |
0.741 |
|
| 2000 |
Westphal EM, Blackstock W, Feng W, Israel B, Kenney SC. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: A potential method for treating EBV-positive malignancies Cancer Research. 60: 5781-5788. PMID 11059774 |
0.302 |
|
| 2000 |
Westphal EM, Ge J, Catchpole JR, Ford M, Kenney SC. The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B- cell lines: Induction of bystander killing in vitro and in vivo Cancer Gene Therapy. 7: 97-106. PMID 10678362 |
0.304 |
|
| 2000 |
Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, Kenney S. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. Journal of Virology. 74: 1224-33. PMID 10627532 DOI: 10.1128/JVI.74.3.1224-1233.2000 |
0.735 |
|
| 1999 |
Adamson AL, Kenney S. The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. Journal of Virology. 73: 6551-8. PMID 10400751 DOI: 10.1128/Jvi.73.8.6551-6558.1999 |
0.736 |
|
| 1999 |
Swenson JJ, Mauser AE, Kaufmann WK, Kenney SC. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. Journal of Virology. 73: 6540-50. PMID 10400750 DOI: 10.1128/Jvi.73.8.6540-6550.1999 |
0.436 |
|
| 1999 |
Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo Cancer Research. 59: 1485-1491. PMID 10197618 |
0.388 |
|
| 1999 |
Zhang Q, Holley-Guthrie E, Dorsky D, Kenney S. Identification of transactivator and nuclear localization domains in the Epstein-Barr virus DNA polymerase accessory protein, BMRF1 Journal of General Virology. 80: 69-74. PMID 9934686 DOI: 10.1099/0022-1317-80-1-69 |
0.488 |
|
| 1998 |
Adamson AL, Kenney SC. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Virology. 251: 187-97. PMID 9813214 DOI: 10.1006/viro.1998.9396 |
0.753 |
|
| 1998 |
Kenney S, Ge JIQ, Westphal EM, Olsen J. Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: Comparison of two different Epstein-Barr virus-based vectors Human Gene Therapy. 9: 1131-1141. PMID 9625252 DOI: 10.1089/Hum.1998.9.8-1131 |
0.468 |
|
| 1997 |
Zhang Q, Holley-Guthrie E, Ge JQ, Dorsky D, Kenney S. The Epstein-Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV oriLyt Virology. 230: 22-34. PMID 9126259 DOI: 10.1006/viro.1997.8470 |
0.456 |
|
| 1997 |
Hong Y, Holley-Guthrie E, Kenney S. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation Virology. 229: 36-48. PMID 9123876 DOI: 10.1006/viro.1996.8413 |
0.534 |
|
| 1997 |
Zalani S, Coppage A, Holley-Guthrie E, Kenney S. The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter Journal of Virology. 71: 3268-3274. PMID 9060693 DOI: 10.1128/Jvi.71.4.3268-3274.1997 |
0.513 |
|
| 1996 |
Rogers RP, Ge JQ, Holley-Guthrie E, Hoganson DK, Comstock KE, Olsen JC, Kenney S. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase. Human Gene Therapy. 7: 2235-45. PMID 8953314 DOI: 10.1089/hum.1996.7.18-2235 |
0.408 |
|
| 1996 |
Zalani S, Holley-Guthrie E, Kenney S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism Proceedings of the National Academy of Sciences of the United States of America. 93: 9194-9199. PMID 8799177 DOI: 10.1073/pnas.93.17.9194 |
0.527 |
|
| 1996 |
Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication Journal of Virology. 70: 5131-5142. PMID 8764021 DOI: 10.1128/Jvi.70.8.5131-5142.1996 |
0.569 |
|
| 1995 |
Zalani S, Holley-Guthrie E, Kenney S. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter Journal of Virology. 69: 3816-3823. PMID 7745729 DOI: 10.1128/Jvi.69.6.3816-3823.1995 |
0.567 |
|
| 1994 |
Gutsch DE, Holley-Guthrie EA, Zhang Q, Stein B, Blanar MA, Baldwin AS, Kenney SC. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B. Molecular and Cellular Biology. 14: 1939-48. PMID 8114725 DOI: 10.1128/Mcb.14.3.1939 |
0.4 |
|
| 1994 |
Zhang Q, Gutsch D, Kenney S. Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency Molecular and Cellular Biology. 14: 1929-1938. PMID 8114724 DOI: 10.1128/Mcb.14.3.1929 |
0.512 |
|
| 1994 |
Furnari FB, Zacny V, Quinlivan EB, Kenney S, Pagano JS. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. Journal of Virology. 68: 1827-36. PMID 8107245 DOI: 10.1128/Jvi.68.3.1827-1836.1994 |
0.597 |
|
| 1994 |
Kenney S, Pagano JS. Viruses as oncolytic agents: A new age for "therapeutic" viruses? Journal of the National Cancer Institute. 86: 1185-1186. PMID 8040882 DOI: 10.1093/jnci/86.16.1185 |
0.301 |
|
| 1994 |
Gutsch DE, Marcu KB, Kenney SC. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters Cellular and Molecular Biology. 40: 747-760. PMID 7812182 |
0.392 |
|
| 1993 |
Quinlivan EB, Holley-Guthrie EA, Morris M, Gutsch D, Bachenheimer SL, Kenney SC. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1 Nucleic Acids Research. 21: 1999-2007. PMID 8393562 DOI: 10.1093/nar/21.14.3340-a |
0.451 |
|
| 1993 |
Sista ND, Pagano JS, Liao W, Kenney S. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection Proceedings of the National Academy of Sciences of the United States of America. 90: 3894-3898. PMID 8387200 DOI: 10.1073/Pnas.90.9.3894 |
0.466 |
|
| 1992 |
Zalani S, Holley-Guthrie EA, Gutsch DE, Kenney SC. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor Journal of Virology. 66: 7282-7292. PMID 1331521 |
0.432 |
|
| 1992 |
Quinlivan EB, Norris M, Bouldin TW, Suzuki K, Meeker R, Smith MS, Hall C, Kenney S. Subclinical central nervous system infection with JC virus in patients with AIDS. The Journal of Infectious Diseases. 166: 80-5. PMID 1318912 DOI: 10.1093/Infdis/166.1.80 |
0.302 |
|
| 1992 |
Kenney SC, Holley-Guthrie E, Quinlivan EB, Gutsch D, Zhang Q, Bender T, Giot JF, Sergeant A. The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells Molecular and Cellular Biology. 12: 136-146. PMID 1309587 DOI: 10.1128/mcb.12.1.136-146.1992 |
0.459 |
|
| 1991 |
Sung NS, Kenney S, Gutsch D, Pagano JS. EBNA-2 Transactivates a Lymphoid-Specific Enhancer in the BamHI C Promoter of Epstein-Barr Virus Journal of Virology. 65: 2164-2169. PMID 1850003 DOI: 10.1128/Jvi.65.5.2164-2169.1991 |
0.549 |
|
| 1990 |
Holley-Guthrie EA, Quinvlivan EB, Mar EC, Kenney S. The Epstein- Barr Virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner Journal of Virology. 64: 3753-3759. PMID 2164595 DOI: 10.1128/Jvi.64.8.3753-3759.1990 |
0.531 |
|
| 1990 |
Byrd Quinlivan E, Holley-Guthrie E, Mar EC, Smith MS, Kenney S. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent Journal of Virology. 64: 1817-1820. PMID 2157062 DOI: 10.1128/Jvi.64.4.1817-1820.1990 |
0.443 |
|
| 1989 |
Markovitz DM, Kenney S, Kamine J, Smith MS, Davis M, Huang ES, Rosen C, Pagano JS. Disparate effects of two herpesviruses immediate-early gene trans-activators on the HIV-1 LTR Virology. 173: 750-754. PMID 2556854 DOI: 10.1016/0042-6822(89)90591-6 |
0.471 |
|
| 1989 |
Kenney S, Holley-Guthrie E, Mar EC, Smith M. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators Journal of Virology. 63: 3878-3883. PMID 2548003 DOI: 10.1128/Jvi.63.9.3878-3883.1989 |
0.495 |
|
| 1989 |
Kenney S, Kamine J, Holley-Guthrie E, Mar EC, Lin JC, Markovitz D, Pagano J. The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent Journal of Virology. 63: 3870-3877. PMID 2548002 DOI: 10.1128/Jvi.63.9.3870-3877.1989 |
0.5 |
|
| 1989 |
Kenney S, Kamine J, Holley-Guthrie EH, Lin JC, Mar EC, Pagano J. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters Journal of Virology. 63: 1729-1736. PMID 2538653 DOI: 10.1128/Jvi.63.4.1729-1736.1989 |
0.543 |
|
| 1988 |
Pagano JS, Kenney S, Markovitz D, Kamine J. Epstein-Barr virus and interactions with human retroviruses Journal of Virological Methods. 21: 229-239. PMID 2846614 DOI: 10.1016/0166-0934(88)90069-9 |
0.425 |
|
| 1988 |
Kenney S, Kamine J, Markovitz D, Fenrick R, Pagano J. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat Proceedings of the National Academy of Sciences of the United States of America. 85: 1652-1656. PMID 2830625 DOI: 10.1073/Pnas.85.5.1652 |
0.473 |
|
| 1984 |
Kenney S, Natarajan V, Strike D, Khoury G, Salzman NP. JC virus enhancer-promoter active in human brain cells. Science (New York, N.Y.). 226: 1337-9. PMID 6095453 DOI: 10.1126/Science.6095453 |
0.304 |
|
| Show low-probability matches. |